中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 3
Mar.  2007
Turn off MathJax
Article Contents

氧化苦参碱联合二甲双胍对非酒精性脂肪肝患者胰岛素抵抗及血清TNFα的影响

  • Published Date: 2007-03-20
  • To assess the therapeutic effect of oxymatrine combined with metformin on insulin resistance index and serum TNF-α in patients with non-alcoholic fatty liver.48 patients with non-alcoholic fatty liver were randomly divided into experiment group treated with oxymatrine combined with metformin (n=24) and control group treated with oxymatrine combined with vitamin c (n=24) for consecutive 4-6 months.Serum transaminaswe level (ALT, AST) , TNF-α, insulin resistance index (IRI) and liver/spleen CT index were detected before and after treatment respectively.All data were processed with statistics.The levels of serum ALT in experiment group were obviously reduced at the end point compared with those of control group (P<0.05) .The levels of IRI and serum TNF-alpha in experiment group were all significantly decreased at the end point compared with those of control group (P<0.05) .Meanwhile, liver/ spleen CT index in experiment group were obviously increased after treatment compared with that of control group (p<0.01) .And no severe side-effects occurred during the experiment.Oxymatrine combined with metformin was an effective and safe remedy for treating on non-alcoholic fatty liver.The mechanism might be related to the reduction of IRI and serum TNF-TNF-α.

     

  • loading
  • [1] 姚光弼, 范上达, 廖家杰.临床肝脏病学[M].上海:上海科学技术出版社, 2004∶550-580.
    [2]Day CP.The potential role of genes in nonalcoholic fatty liver disease[J].Clin Liver Dis, 2004, 8 (3) ∶673-691.
    [3]Choudhury J, Sanyal AJ.Insulin resistance and the pathogenesis ofnonalcoholic fatty liver disease[J].Clin Liver Dis, 2004, 8 (3) ∶575-594.
    [4]Bugianesi E, Zannoni C, Vanni E, et al.Non-alcoholic fatty liverand insulin resistance:a cause-effect relationship?[J].Dig LiverDis, 2004, 36 (3) ∶165-173.
    [5]Videla LA, Rodrigo R, Araya J, et al.Oxidative stress and deple-tion of hepatic long-chain polyunsaturated fatty acids may contributeto nonalcoholic fatty liver disease[J].Free Radic Biol Med, 2004, 37 (9) ∶1499-1507.
    [6]Yu XH, Zhu JS, Yu HF, et al.Immunomodulatory effect ofoxymatrine on induced CCl4-hepatic fibrosis in rats[J].Chin MedJ, 2004, 117 (12) ∶1856-1858.
    [7]Tokar JL, Berg CL.Therapeutic Options in Nonalcoholic Fatty LiverDisease[J].Curr Treat Options Gastroenterol, 2002, 5 (6) ∶425-436.
    [8]Hundal RS, Inzucchi SE.Metformin:newunderstandings, newuses[J].Drugs, 2003, 63 (18) ∶1879-1894.
    [9]Diehl AM.Tumor necrosis factor and its potential role in insulin re-sistance and nonalcoholic fatty liver disease[J].Clin Liver Dis, 2004, 8 (3) ∶619-638.
    [10]Lin HZ, Yang SQ, Chuckaree C, et al.Metformin reverses fattyliver disease in obese, leptin-deficient mice[J].Nat Med, 2000, 6 (9) ∶998-1003.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2089) PDF downloads(659) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return